Kenei Furukawa

2.6k total citations
203 papers, 1.9k citations indexed

About

Kenei Furukawa is a scholar working on Oncology, Surgery and Hepatology. According to data from OpenAlex, Kenei Furukawa has authored 203 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Oncology, 99 papers in Surgery and 64 papers in Hepatology. Recurrent topics in Kenei Furukawa's work include Pancreatic and Hepatic Oncology Research (62 papers), Hepatocellular Carcinoma Treatment and Prognosis (48 papers) and Inflammatory Biomarkers in Disease Prognosis (39 papers). Kenei Furukawa is often cited by papers focused on Pancreatic and Hepatic Oncology Research (62 papers), Hepatocellular Carcinoma Treatment and Prognosis (48 papers) and Inflammatory Biomarkers in Disease Prognosis (39 papers). Kenei Furukawa collaborates with scholars based in Japan, United States and China. Kenei Furukawa's co-authors include Koichiro Haruki, Katsuhiko Yanaga, Hiroaki Shiba, Yuki Fujiwara, Takeyuki Misawa, Yoshihiro Shirai, Takeshi Gocho, Toru Ikegami, Ryota Iwase and Shinji Onda and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Kenei Furukawa

178 papers receiving 1.9k citations

Peers

Kenei Furukawa
Kenei Furukawa
Citations per year, relative to Kenei Furukawa Kenei Furukawa (= 1×) peers Yuki Kitano

Countries citing papers authored by Kenei Furukawa

Since Specialization
Citations

This map shows the geographic impact of Kenei Furukawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenei Furukawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenei Furukawa more than expected).

Fields of papers citing papers by Kenei Furukawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenei Furukawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenei Furukawa. The network helps show where Kenei Furukawa may publish in the future.

Co-authorship network of co-authors of Kenei Furukawa

This figure shows the co-authorship network connecting the top 25 collaborators of Kenei Furukawa. A scholar is included among the top collaborators of Kenei Furukawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenei Furukawa. Kenei Furukawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsunematsu, Masashi, Kenei Furukawa, Koichiro Haruki, et al.. (2024). The prognosis-based classification model in resectable pancreatic cancer. Surgical Oncology. 52. 102035–102035. 1 indexed citations
2.
Furukawa, Kenei, Koichiro Haruki, Masashi Tsunematsu, et al.. (2024). Prognostic significance of occult vertebral fracture in patients undergoing pancreatic resection for pancreatic cancer. Pancreatology. 24(2). 249–254. 2 indexed citations
3.
Tsunematsu, Masashi, Koichiro Haruki, Yoshihiro Shirai, et al.. (2024). The Signal Intensity Ratio of Pancreas to Spleen in Magnetic Resonance Imaging Can Predict Nonalcoholic Fatty Liver Disease After Pancreaticoduodenectomy. Pancreas. 53(4). e310–e316.
4.
Furukawa, Kenei, Michinori Matsumoto, Yasuro Futagawa, et al.. (2024). Osteosarcopenia impacts treatment outcomes for Barcelona Cancer Liver Classification stage A hepatocellular carcinoma. Surgical Oncology. 53. 102043–102043. 3 indexed citations
5.
Furukawa, Kenei, Masashi Tsunematsu, Ryoga Hamura, et al.. (2024). Timing of TS1 adjuvant chemotherapy as a prognostic factor in recurrent pancreatic cancer after surgery. Surgical Oncology. 58. 102179–102179. 2 indexed citations
6.
Kamada, Teppei, Eisaku Ito, Kenei Furukawa, et al.. (2024). Novel body component score predicts long‐term survival in patients with stage I–III colorectal cancer following radical resection. Annals of Gastroenterological Surgery. 9(3). 529–537.
7.
Shirai, Yoshihiro, Shinji Onda, Ryoga Hamura, et al.. (2023). Superior mesenteric vein/portal vein contact in preoperative imaging indicates biological malignancy in anatomically resectable pancreatic cancer. Surgical Oncology. 51. 101998–101998. 1 indexed citations
8.
Haruki, Koichiro, Tomohiko Taniai, Kenei Furukawa, et al.. (2023). The Japanese 5-5-500 Rule Predicts Prognosis of Hepatocellular Carcinoma After Hepatic Resection. Anticancer Research. 43(4). 1623–1629. 3 indexed citations
9.
Furukawa, Kenei, Tomohiko Taniai, Koichiro Haruki, et al.. (2023). Blood loss in laparoscopic distal pancreatectomy could be underestimated. Journal of Hepato-Biliary-Pancreatic Sciences. 30(7). 962–969. 2 indexed citations
10.
Yasuda, Jungo, et al.. (2023). Double cone-unit laparoscopic hepatic resection for tumors adjacent to the hepatic vein. Surgical Oncology. 48. 101926–101926.
11.
Haruki, Koichiro, Kenei Furukawa, Shinji Onda, et al.. (2023). A novel combined C‐reactive protein‐albumin ratio and modified albumin‐bilirubin score can predict long‐term outcomes in patients with hepatocellular carcinoma after hepatic resection. Annals of Gastroenterological Surgery. 8(1). 143–150. 5 indexed citations
12.
Gocho, Takeshi, Tomohiko Taniai, Tadashi Uwagawa, et al.. (2022). Conversion surgery for undifferentiated carcinoma with osteoclast-like giant cells of the pancreas: a case report. SHILAP Revista de lepidopterología. 8(1). 42–42. 5 indexed citations
14.
Tsunematsu, Masashi, Takeshi Gocho, Mitsuru Yanagaki, et al.. (2022). The impact of postoperative exocrine index on non‐alcoholic fatty liver disease following pancreaticoduodenectomy. Annals of Gastroenterological Surgery. 6(5). 704–711. 6 indexed citations
15.
Hamura, Ryoga, Shinji Onda, Yoshihiro Shirai, et al.. (2022). Safe perioperative management of major hepatectomy in a patient with portal hypertension after elimination of hepatitis C: a case report. SHILAP Revista de lepidopterología. 8(1). 3–3.
16.
Matsumoto, Michinori, Kyohei Abe, Yasuro Futagawa, et al.. (2021). New Scoring System for Prediction of Surgical Difficulty During Laparoscopic Cholecystectomy After Percutaneous Transhepatic Gallbladder Drainage. Annals of Gastroenterological Surgery. 6(2). 296–306. 6 indexed citations
17.
Takahashi, Keita, Katsunori Nishikawa, Kenei Furukawa, et al.. (2021). Prognostic Significance of Preoperative Osteopenia in Patients Undergoing Esophagectomy for Esophageal Cancer. World Journal of Surgery. 45(10). 3119–3128. 18 indexed citations
18.
Shiba, Hiroaki, Yuichi Ishida, Yuki Fujiwara, et al.. (2013). Practice to minimize the use of blood products improve outcome after hepatic resection for hepatocellular carcinoma.. PubMed. 60(127). 1681–3. 13 indexed citations
19.
Fujiwara, Yuki, Hiroaki Shiba, Ryota Iwase, et al.. (2012). Inhibition of Nuclear Factor Kappa-B Enhances the Antitumor Effect of Combination Treatment with Tumor Necrosis Factor-Alpha Gene Therapy and Gemcitabine for Pancreatic Cancer in Mice. Journal of the American College of Surgeons. 216(2). 320–332e3. 16 indexed citations
20.
Shiba, Hiroaki, Yuichi Ishida, Shigeki Wakiyama, et al.. (2009). Negative Impact of Blood Transfusion on Recurrence and Prognosis of Hepatocellular Carcinoma After Hepatic Resection. Journal of Gastrointestinal Surgery. 13(9). 1636–1642. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026